Back to search

Netherlands· NL-12e7ba16e52e

Prucalopride Amarox 2 mg filmomhulde tabletten

A prucalopride product containing prucalopridesuccinaat, registered in Netherlands by Amarox Pharma B.V.. The same ATC class is registered in 15 of our 19 countries.

ATC A06AX05

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedPrucalopride Amarox 2 mg filmomhulde …ATCA06AX05REGISTER NO.NL-12e7ba16e52ePACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Prucalopride is registered in 15 of 19 countries.

Countries holding a registration under ATC A06AX05 (prucalopride), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose

Prucalopride · ATC A06AX05

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of prucalopride costs, country by country.

Normalised to the WHO defined daily dose (2 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Prucalopride · price per daily dose (2 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.84
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
PRUCALOPRIDESUCCINAAT
Manufacturer
Amarox Pharma B.V.
Country
Netherlands (NL)
ATC code
A06AX05
ATC class
Prucalopride
Defined daily dose
2 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    134676

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

127 interactions on record for prucalopride.

Graded by severity as the source publishes them — 57 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Prucalopride · interactions on record

127 records

  • 57 moderate
  • 70 minor

Most severe, free to view

  • DicycloverineA03AA07moderate
  • PropanthelineA03AB05moderate
  • MepenzolateA03AB12moderate
  • TrospiumA03AB20moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Prucalopride in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All prucalopride products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Belgium · Prucalopride Fagron, Prucalopride Koanaa Healthcare
  • Bulgaria · Енилис, Стеркор
  • Cyprus · Absken, Stercore
  • Germany · Prucaloprid Al, Prucaloprid Aristo
  • Denmark · Prucalopride "holsten", Prucalopride Amarox
  • Finland · Prucalopride Stada
  • France · Prucalopride Amarox
  • United Kingdom (Northern Ireland) · Prucalopride, Prucalopride Amarox
  • Greece · Absken
  • Croatia · Abemot, Colopridix
  • Hungary · Prucalopride Supremex, Tsatsago
  • Ireland · Prucalopride, Prucalopride Aristo
  • Iceland · Prucalopride Stada, Pucalopride Stada
  • Liechtenstein · Resolor
  • Malta · Absken, Colopridix
  • Norway · Prucalopride Orifarm, Prucalopride Zentiva
  • Romania · Colselax, Stercore
  • Sweden · Prucalopride Amarox, Prucalopride Axunio
  • Slovenia · Colopridix
  • Slovakia · Stercore

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5189f9af-f39b-4994-b525-9e53ec35e5cc
GET /v1/drugs/5189f9af-f39b-4994-b525-9e53ec35e5cc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h134676_smpc.pdf",
  "strength": null,
  "atc_label": "Prucalopride",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg134676",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "GLYCEROLTRIACETAAT (E 1518)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 3000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "PRUCALOPRIDESUCCINAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h134676.pdf",
  "authorised_at": "2026/08/31",
  "procedure_number": "NL/H/6340/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "134676",
  "additional_monitoring": "N"
}

See everything about prucalopride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.